Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient

Medicine and Dentistry

• Liver Transplantation 100%
• Lorcaserin 100%
• Decompensated Liver Cirrhosis 66%
• Weight Loss 66%
• Complication 33%
• Transplantation 33%
• Body Mass Index 33%
• Obesity 33%
• Portal Hypertension 33%
• Hepatology 33%
• Peroperative Complication 33%
• Liver Graft 33%
• Attributable Risk 33%
• Enalapril Maleate 33%
• Drug 33%
• Chemotherapeutic Agent 33%
• Rupture 33%
• Patient 33%
• Morbid Obesity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Lorcaserin 100%
• Decompensated Liver Cirrhosis 66%
• Complication 33%
• Obesity 33%
• Enalapril Maleate 33%
• Drug 33%
• Morbid Obesity 33%
• Portal Hypertension 33%
• Peroperative Complication 33%
• Rupture 33%